Rhythm Pharmaceuticals buy Wells Fargo & Company
Start price
07.04.25
/
50%
€50.50
Target price
07.04.26
€82.88
Performance (%)
55.45%
Price
27.02.26
€81.50
Summary
This prediction is currently active. The BUY prediction by Wells_Fargo___Compan for Rhythm Pharmaceuticals has seen massive gains of 55.45%. This prediction currently runs until 07.04.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rhythm Pharmaceuticals | -4.118% | -4.118% |
| iShares Core DAX® | -0.383% | 1.093% |
| iShares Nasdaq 100 | -0.411% | -1.973% |
| iShares Nikkei 225® | 1.838% | 10.261% |
| iShares S&P 500 | -0.712% | 0.445% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its price target raised by analysts at Wells Fargo & Company from $80.00 to $91.00. They now have an "overweight" rating on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€78.50
27.02.26
27.02.26
€115.27
27.02.27
27.02.27
0.00%
27.02.26
27.02.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€75.50
10.07.25
10.07.25
€109.86
10.07.26
10.07.26
3.97%
27.02.26
27.02.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€42.40
19.12.23
19.12.23
€48.34
19.12.24
19.12.24
30.90%
20.12.24
20.12.24
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€26.00
08.11.23
08.11.23
€37.40
08.11.24
08.11.24
140.38%
09.11.24
09.11.24